Nebula Genomics

Nebula Genomics is a private, commercial-stage company leveraging whole genome sequencing (WGS) to empower both consumers and researchers. Its core offering is a 30x WGS service, providing significantly more genetic data than typical SNP-based ancestry tests, coupled with a platform for data access and privacy. The company operates a dual business model: a direct-to-consumer (DTC) service and a B2B research division that enables sponsored sequencing for clinical and observational studies. Co-founded by renowned geneticist George Church, Nebula differentiates itself on data completeness, user ownership, and its research partnerships.

Whole genome sequencing (30x/100x coverage) coupled with a software platform for data access, exploration, and privacy management. Utilizes blockchain-inspired technology for data security and user-controlled access.

In DTC, Nebula competes with 23andMe and Ancestry on the low-end (SNP arrays) and companies like Dante Labs and Veritas Genetics on the high-end (WGS). In research services, it competes with large sequencing service providers (e.g., Illumina, LabCorp) and CROs that offer genomic components. Its differentiation lies in its high-coverage WGS, strong privacy focus, and unique participant-engagement model for research.